» Articles » PMID: 29914406

Management of Patients with Persistent Medically Unexplained Symptoms: a Descriptive Study

Overview
Journal BMC Fam Pract
Publisher Biomed Central
Date 2018 Jun 20
PMID 29914406
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In 2013 the Dutch guideline for management of medically unexplained symptoms (MUS) was published. The aim of this study is to assess medical care for patients with persistent MUS as recorded in their electronic medical records, to investigate if this is in line with the national guideline for persistent MUS and whether there are changes in care over time.

Methods: We conducted an observational study of adult primary care patients with MUS. Routinely recorded health care data were extracted from electronic medical records of patients participating in an ongoing randomised controlled trial in 30 general practices in the Netherlands. Data on general practitioners' (GPs') management strategies during MUS consultations were collected in a 5-year period for each patient prior. Management strategies were categorised according to the options offered in the Dutch guideline. Changes in management over time were analysed.

Results: Data were collected from 1035 MUS consultations (77 patients). Beside history-taking, the most frequently used diagnostic strategies were physical examination (24.5%) and additional investigations by the GP (11.1%). Frequently used therapeutic strategies were prescribing medication (24.6%) and providing explanations (11.2%). As MUS symptoms persisted, GPs adjusted medication, discussed progress and scheduled follow-up appointments more frequently. The least frequently used strategies were exploration of all complaint dimensions (i.e. somatic, cognitive, emotional, behavioural and social) (3.5%) and referral to a psychologist (0.5%) or psychiatrist (0.1%).

Conclusions: Management of Dutch GPs is partly in line with the Dutch guideline. Medication was possibly prescribed more frequently than recommended, whereas exploration of all complaint dimensions, shared problem definition and referral to mental health care were used less.

Citing Articles

The burden of persistent symptom diagnoses in primary care patients: a cross-sectional study.

Chaabouni A, Houwen J, Grewer G, Liebau M, Akkermans R, van Boven K Scand J Prim Health Care. 2024; 42(1):112-122.

PMID: 38189313 PMC: 10851811. DOI: 10.1080/02813432.2023.2293930.


Understanding Patient-Provider Interaction, Treatment Acceptance, and Outcomes in Medically Unexplained Symptoms.

Bellman V, Zolnikov T Cureus. 2023; 14(12):e32915.

PMID: 36699771 PMC: 9871694. DOI: 10.7759/cureus.32915.


Symptom attribution and stress level in patients with medically unexplained symptoms in a Mexican emergency department.

Ramirez Aranda J, Gonzalez Sanchez M, Hernandez Guedea M, Ordonez Azuara Y, Trevino Uresti Y, Barahona Heredia S J Family Med Prim Care. 2022; 11(9):5129-5134.

PMID: 36505573 PMC: 9731031. DOI: 10.4103/jfmpc.jfmpc_2254_21.


The Careful Assessment Tool for Managing Patients with Medically Unexplained Symptoms - the Experience of Slovenian Family Medicine Trainees: a Qualitative Study.

Ivetic V, Martinjak S, Maksuti A Zdr Varst. 2022; 61(1):48-54.

PMID: 35111266 PMC: 8776293. DOI: 10.2478/sjph-2022-0008.


Identifying persistent somatic symptoms in electronic health records: exploring multiple theory-driven methods of identification.

Kitselaar W, Numans M, Sutch S, Faiq A, Evers A, van der Vaart R BMJ Open. 2021; 11(9):e049907.

PMID: 34535479 PMC: 8451292. DOI: 10.1136/bmjopen-2021-049907.


References
1.
Sirri L, Grandi S, Tossani E . Medically unexplained symptoms and general practitioners: a comprehensive survey about their attitudes, experiences and management strategies. Fam Pract. 2017; 34(2):201-205. DOI: 10.1093/fampra/cmw130. View

2.
Austad B, Hetlevik I, Mjolstad B, Helvik A . Applying clinical guidelines in general practice: a qualitative study of potential complications. BMC Fam Pract. 2016; 17:92. PMC: 4957916. DOI: 10.1186/s12875-016-0490-3. View

3.
Konnopka A, Schaefert R, Heinrich S, Kaufmann C, Luppa M, Herzog W . Economics of medically unexplained symptoms: a systematic review of the literature. Psychother Psychosom. 2012; 81(5):265-75. DOI: 10.1159/000337349. View

4.
de Waal M, Arnold I, Eekhof J, van Hemert A . Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders. Br J Psychiatry. 2004; 184:470-6. DOI: 10.1192/bjp.184.6.470. View

5.
Clark R, Tonmukayakul U, Mangan Y, Smith M, Gussy M, Manton D . Measuring Adherence to Evidence-Based Clinical Practice Guidelines. J Evid Based Dent Pract. 2017; 17(4):301-309. DOI: 10.1016/j.jebdp.2017.05.001. View